Longkou Union Chemical Co., Ltd. (SHE:301209)
China · Delayed Price · Currency is CNY 38.46
-1.49 (-3.73%)
Nov 6, 2026, 3:04 PM CST
Longkou Union Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 514.41 | 512.12 | 534.18 | 427.47 | 541.94 | 551.67 |
Other Revenue | 0 | 0 | 0.44 | 0.91 | 0.05 | 0.27 |
| 514.41 | 512.12 | 534.62 | 428.39 | 541.98 | 551.94 | |
Revenue Growth | -2.85% | -4.21% | 24.80% | -20.96% | -1.80% | 16.81% |
Cost of Revenue | 417.24 | 409.98 | 433.54 | 362.61 | 449.2 | 439.04 |
Gross Profit | 97.17 | 102.15 | 101.07 | 65.78 | 92.78 | 112.9 |
Selling, General & Admin | 22.07 | 22.04 | 20.64 | 17.17 | 20.02 | 13.44 |
Research & Development | 22.02 | 22.57 | 24.21 | 19.04 | 21.81 | 21.71 |
Other Operating Expenses | 2.41 | 0.67 | 2.37 | 2.16 | 2.84 | 3.28 |
Operating Expenses | 47.73 | 44 | 48.34 | 38.31 | 42.52 | 40.53 |
Operating Income | 49.44 | 58.15 | 52.74 | 27.47 | 50.26 | 72.37 |
Interest Expense | -1.97 | -0.73 | - | - | - | - |
Interest & Investment Income | 4.51 | 6.16 | 9.42 | 7.63 | 3.03 | 0.65 |
Currency Exchange Gain (Loss) | -3.02 | -3.02 | 2.36 | 1.09 | 6.37 | -1.43 |
Other Non Operating Income (Expenses) | -5.76 | -0.16 | -0.07 | -0.16 | -0.13 | -0.14 |
EBT Excluding Unusual Items | 43.2 | 60.39 | 64.46 | 36.03 | 59.53 | 71.45 |
Gain (Loss) on Sale of Investments | -34.36 | -2.14 | 0.4 | 0.62 | 0.38 | -0 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.05 | 0.1 |
Asset Writedown | -0.24 | -0.06 | -0.11 | -0.46 | -0.3 | -0.79 |
Other Unusual Items | 0.64 | 1.11 | -1.15 | 1.47 | 11.2 | 4.94 |
Pretax Income | 9.24 | 59.3 | 63.6 | 37.67 | 70.85 | 75.7 |
Income Tax Expense | 3.94 | 6.72 | 7.16 | 3.84 | 6.7 | 8.48 |
Earnings From Continuing Operations | 5.31 | 52.58 | 56.43 | 33.83 | 64.15 | 67.21 |
Minority Interest in Earnings | 0.6 | 0.06 | - | - | - | - |
Net Income | 5.91 | 52.64 | 56.43 | 33.83 | 64.15 | 67.21 |
Net Income to Common | 5.91 | 52.64 | 56.43 | 33.83 | 64.15 | 67.21 |
Net Income Growth | -90.11% | -6.71% | 66.81% | -47.27% | -4.55% | 13.51% |
Shares Outstanding (Basic) | 192 | 157 | 157 | 157 | 131 | 118 |
Shares Outstanding (Diluted) | 192 | 157 | 157 | 157 | 131 | 118 |
Shares Change | 55.53% | 0.01% | 0.02% | 19.98% | 11.10% | 4.38% |
EPS (Basic) | 0.03 | 0.34 | 0.36 | 0.22 | 0.49 | 0.57 |
EPS (Diluted) | 0.03 | 0.34 | 0.36 | 0.22 | 0.49 | 0.57 |
EPS Growth | -93.64% | -6.72% | 66.77% | -56.05% | -14.09% | 8.75% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 54.27 | 96.07 | 33.01 | 52.28 | 55.14 | 21.54 |
Free Cash Flow Per Share | 0.28 | 0.61 | 0.21 | 0.33 | 0.42 | 0.18 |
Dividend Per Share | 0.150 | 0.150 | 0.143 | 0.061 | 0.092 | - |
Dividend Growth | 46.91% | 4.97% | 133.50% | -33.33% | - | - |
Gross Margin | 18.89% | 19.95% | 18.91% | 15.36% | 17.12% | 20.46% |
Operating Margin | 9.61% | 11.35% | 9.86% | 6.41% | 9.27% | 13.11% |
Profit Margin | 1.15% | 10.28% | 10.56% | 7.90% | 11.84% | 12.18% |
Free Cash Flow Margin | 10.55% | 18.76% | 6.17% | 12.20% | 10.17% | 3.90% |
EBITDA | 65.94 | 74.17 | 68.12 | 42.27 | 63.56 | 85.89 |
EBITDA Margin | 12.82% | 14.48% | 12.74% | 9.87% | 11.73% | 15.56% |
D&A For EBITDA | 16.51 | 16.02 | 15.38 | 14.8 | 13.3 | 13.52 |
EBIT | 49.44 | 58.15 | 52.74 | 27.47 | 50.26 | 72.37 |
EBIT Margin | 9.61% | 11.35% | 9.86% | 6.41% | 9.27% | 13.11% |
Effective Tax Rate | 42.59% | 11.33% | 11.27% | 10.19% | 9.45% | 11.21% |
Revenue as Reported | 514.41 | 512.12 | 534.62 | 428.39 | 541.98 | 551.94 |